|
 |
Candesartan cilexetilThis page contains recent news articles, when available, and an overview of Candesartan cilexetil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....block copolymers on their self-assembling properties, the loading and the release of poorly water soluble drug; candesartan cilexetil (CDN). ... Insciences Organisation Takeda signs obesity deal with Amylin worth over $1 billion - Nov 2, 2009 Sales of the blood pressure drug Blopress (candesartan cilexetil) were down 5.8% to 112.40 billion yen, while turnover from the prostate cancer treatment ... Pharma Times Blopress Plus - Nov 2, 2009 Indication: Essential Hypertension, where monotherapy with candesartan cilexetil or hydrocholorothiazide (HCTZ) is not sufficient. ... Irish Medical Times … AstraZeneca's ATACAND(R) (Candesartan Cilexetil) for the Treatment... - Feb 23, 2005 WILMINGTON, Del., Feb. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin ... RedOrbit Candesartan Cilexetil - a Review of Effects on Cardiovascular … - Aug 2, 2007 By Meredith, Peter A. Therapeutic interventions that block the renin-angiotensin- aldosterone system (RAAS) have an important role in slowing the ... RedOrbit FDA Approves Candesartan Cilexetil for the Treatment of Heart Failure - Mar 1, 2005 Takeda Pharmaceutical Company Limited ("Takeda") announced today that the US Food and Drug Administration (FDA) has approved its angiotensin receptor ... i-newswire.com … Of Medicine Evaluates Effects Of ATACAND(R) (candesartan Cilexetil) - Apr 21, 2006 ATACAND(R) (candesartan cilexetil) is not indicated to prevent the development ... During concomitant use of ATACAND(R) (candesartan cilexetil) and lithium, ... Medical News Today - Medical News Today (press release) … Astrazeneca's Atacand(R) (Candesartan Cilexetil) For The Treatment... - Feb 25, 2005 Atacand is first ARB to receive approval for reducing both CV mortality and hospitalizations for heart failure - AstraZeneca today announced that the US ... Medical News Today - Medical News Today (press release) candesartan cilexetil AstraZeneca clinical data (hypertension). - Mar 27, 2006 On 14 March 2006 AstraZeneca reported results from a four-year US clinical trial of candesartan cilexetil (ATACAND), designated TROPHY (Trial Of Preventing ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones … has announced that Amias (candesartan cilexetil) has been acce - May 10, 2005 Amias (candesartan cilexetil), which is marketed in the UK by Takeda UK, is the first ARB to be licensed in the UK for use in patients with CHF with LVSD ... OnMedica Candesartan cilexetil + hydrochlorothiazide Takeda marketed, Saudi … - Jan 17, 2005 ...candesartan cilexetil + hydrochlorothiazide, hydrochlorothiazide + candesartan cilexetil, TCV 116C, ATACAND HCT, ATACAND PLUS, HYTACAND, BLOPRESS R, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Atacand - Candesartan cilexetil - Medical Drug - Jul 1, 2008 Blood pressure is important to supply blood around the body, but when blood pressure becomes higher than normal, it may cause damage to blood vessels in ... Virtual Medical Centre - The Virtual Medical Centre Novel Trophy Study Is First To Evaluate Effects Of Pharmacological … - Mar 18, 2006 In addition, ATACAND® (candesartan cilexetil) is indicated for the treatment of ... When pregnancy is detected, ATACAND® (candesartan cilexetil) should be ... Medical News Today - Medical News Today (press release) … AstraZeneca's ATACAND(R) (Candesartan Cilexetil) for Use With an … - May 19, 2005 WILMINGTON, Del., May 19 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved a new use for its ... RedOrbit … Combined Use of ATACAND(R) (candesartan cilexetil) and ACE... - May 4, 2006 Combined Use of ATACAND(R) (candesartan cilexetil) and ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research AstraZeneca Submits For New Dosage Strengths Of Atacand Plus - New … - Jul 1, 2008 Candesartan cilexetil is marketed by AstraZeneca under trademark Atacand®, ... Combination therapy with candesartan cilexetil and hydrochlorothiazide in ... Medical News Today - Medical News Today (press release) … Effects of ATACAND(R) (Candesartan Cilexetil) on the Development... - Sep 6, 2005 ATACAND(R) (candesartan cilexetil), in reducing the risk of development of diabetes in patients with heart failure and no previous diagnosis of diabetes ... RedOrbit Abstract and Introduction - May 15, 2006 Conclusion: Compared with candesartan cilexetil 8mg, greater proportions of olmesartan medoxomil-treated patients (20mg) achieved ESH/ESC and JSH ABPM goals ... Medscape … Significantly Reduced by Candesartan Cilexetil Therapy in Heart... - Jul 5, 2006 Atrial fibrillation is associated with a decline in cardiac function and worsening of heart failure symptoms including reduction in exercise capacity as ... DG News candesartan cilexetil Takeda registered, Japan (heart failure). - Oct 24, 2005 Takeda announced on 11 October 2005 that 2 mg, 4 mg and 8 mg tablet formulations of candesartan cilexetil (BLOPRESS) have been approved by the Japanese ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones … AstraZeneca's ATACAND(R) (candesartan cilexetil) for the Treatment... - Feb 23, 2005 FDA Approves AstraZeneca's ATACAND(R) (candesartan cilexetil) for the Treatment of Heart Failure. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research DIRECT-Renal: Candesartan did not prevent microalbuminuria - Nov 12, 2008 PHILADELPHIA — Researchers reported no statistical benefit of candesartan cilexetil in the prevention of microalbuminuria in patients with diabetes over a ... Endocrine Today Novel TROPHY Study Is First to Evaluate Effects of Pharmacological … - Mar 14, 2006 In addition, ATACAND(R) (candesartan cilexetil) is indicated for the treatment ... When pregnancy is detected, ATACAND(R) (candesartan cilexetil) should be ... $4.95 - PR Newswire - ECNext … AstraZeneca's ATACAND(R) (candesartan cilexetil) for Use With an... - May 19, 2005 FDA Approves AstraZeneca's ATACAND(R) (candesartan cilexetil) for Use With an ACE Inhibitor in the Treatment of Heart Failure. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research TROPHY Trial: Incidence of hypertension reduced with early interventio... - Mar 22, 2006 Half of the participants were given candesartan cilexetil for two years and then were removed from the medication for two years; the other half of the group ... RxPG NEWS … Effects of ATACAND(R) (candesartan cilexetil) on the Development... - Sep 6, 2005 CHARM Program Evaluates Effects of ATACAND(R) (candesartan cilexetil) on the Development of Diabetes in Patients With Heart Failure. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Consortium Accepts Amias(R) (candesartan cilexetil) for the... - May 9, 2005 Scottish Medicines Consortium Accepts Amias(R) (candesartan cilexetil) for the Treatment of Chronic Heart Failure in Patients With Left Ventricular Systolic ... Pay-Per-View - PR Newswire Europe - HighBeam Research Developing nanoparticle formulations of poorly soluble drugs:... - Nov 1, 2008 ...such as Ketoconazole, Fenofibrate and Candesartan cilexetil, would enable the revival of these marketed products with improved bioavailability, ... $9.94 - Pharmaceutical Technology Europe - Alacra Store Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 Bisoprolol Fumarate Bisoprolol Fumarate; Hydrochlorothiazide C Candesartan Cilexetil Candesartan Cilexetil; Hydrochlorothiazide Carbamazepine Carbidopa; ... Pay-Per-View - Federal Register 2007 - Loislaw Takeda goes it alone.(Amias candesartan cilexetil)(Brief Article) - Jan 12, 2005 Amias (candesartan cilexetil), licensed for the treatment of essential hypertension, is being exclusively marketed in the UK by Takeda UK. $4.95 - Community Pharmacy - ECNext Press Release: Forest Laboratories Announces Completion of Acquisition... - Jan 11, 2007 ...with an angiotensin receptor blocker (ARB) for heart failure, AstraZeneca's ATACAND(R) (candesartan cilexetil), has been shown to improve survival ... ... Pay-Per-View - PR Newswire - HighBeam Research Incidence Of Atrial Fibrillation Significantly Reduced By Candesartan... - Jul 16, 2006 Candesartan cilexetil was discovered and originally synthesized by Takeda Pharmaceutical ... Candesartan cilexetil is marketed by Takeda as Blopressо, ... Medical News Today - Medical News Today (press release) candesartan cilexetil AstraZeneca receives approval for additional … - May 30, 2005 ...and to reduce heart failure hospitalizations. In addition to the approval for heart failure in February 2005, this approval will allow the use of ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Heart Failure; US FDA approves candesartan cilexetil for the treatment... - Mar 22, 2005 2005 MAR 22 - (NewsRx.com) -- AstraZeneca announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Study finds incidence of hypertension reduced with early intervention - Mar 14, 2006 Half of the participants were given candesartan cilexetil for two years and then were removed from the medication for two years; the other half of the group ... eurekalert.org Heart Failure; US FDA approves candesartan cilexetil for the treatment... - Mar 25, 2005 2005 MAR 25 - (NewsRx.com) -- AstraZeneca announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Heart Failure; US FDA approves candesartan cilexetil for the treatment... - Mar 27, 2005 2005 MAR 27 - (NewsRx.com) -- AstraZeneca announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Combined Use Of Atacand(R) And ACE Inhibitor Improves Heart Failure … - May 5, 2006 Patients were randomized to either ATACAND(R) (candesartan cilexetil) or matching ... In the CHARM program, comparing ATACAND(R) (candesartan cilexetil) in ... Medical News Today - Medical News Today (press release) Press Release: Dr. James Young Appointed Principal Investigator for … - Sep 19, 2007 Article: FDA Approves AstraZeneca's ATACAND(R) (candesartan cilexetil) for ... ... Article: Combined Use of ATACAND(R) (candesartan cilexetil) and ACE ... ... Pay-Per-View - PR Newswire - HighBeam Research … JAMA Evaluates Effect of ATACAND(R) (candesartan cilexetil) on... - Oct 11, 2005 Patients were randomized to either ATACAND(R) (candesartan cilexetil) or matching placebo initiated at 4 mg or 8 mg once daily and titrated as tolerated to ... $4.95 - PR Newswire - ECNext AstraZeneca; Atacand in patients with prehypertension study showed … - May 15, 2006 Atacand (candesartan cilexetil) is not indicated to prevent the development of hypertension or for the treatment of prehypertension. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones FDA Approvals: Proquin XR, Atacand, Pegasys - May 26, 2005 Candesartan cilexetil was previously approved in the US and the European Union (EU) for use alone or in combination with other antihypertensive agents to ... Medscape Press Release: Novel Study Published in New England Journal of … - Apr 20, 2006 ATACAND(R) (candesartan cilexetil) is not indicated to prevent the development of hypertension or for the treatment of prehypertension. ... Pay-Per-View - PR Newswire - HighBeam Research First large-scale international clinical programme for treatment of... - Jun 5, 2005 DIRECT is the first clinical trial programme designed to establish whether treatment with an angiotensin receptor blocker (ARB), candesartan cilexetil, ... i-newswire.com First large-scale international clinical programme for treatment of... - Jun 2, 2005 DIRECT is the first clinical trial programme designed to establish whether treatment with an angiotensin receptor blocker (ARB), candesartan cilexetil, ... Medical News Today - Medical News Today (press release) FDA Safety Labeling Changes: Duragesic, Candesartan, Serostim LQ - Apr 27, 2005 Candesartan cilexetil is indicated for use alone or in combination with other agents for the treatment of hypertension and to reduce the risk of ... Medscape Abstract and Introduction - Dec 6, 2005 Candesartan cilexetil: an angiotensin II receptor blocker. Ann Pharmacother. 1999; 33: 1287-98. Greathouse M. A review of olmesartan medoxomil monotherapy: ... Medscape Diabetes Control; Angiotensin II receptor blockade protects heart... - Apr 18, 2005 According to published research from Turkey, "We investigated the effect of treatment with an angiotensin II receptor blocker, candesartan-cilexetil, ... Pay-Per-View - Diabetes Week - Factiva, from Dow Jones Diabetes Control; Angiotensin II receptor blockade protects heart... - Apr 19, 2005 According to published research from Turkey, "We investigated the effect of treatment with an angiotensin II receptor blocker, candesartan-cilexetil, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Diabetes Control; Angiotensin II receptor blockade protects heart... - Apr 23, 2005 According to published research from Turkey, "We investigated the effect of treatment with an angiotensin II receptor blocker, candesartan-cilexetil, ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Press Release: New Analysis of CHARM Program Published in JAMA … - Oct 11, 2005 Article: Combined Use of ATACAND(R) (candesartan cilexetil) and ACE ... PR Newswire; May 4, 2006 ; 700+ words ... ... the benefits of adding ATACAND to ... Pay-Per-View - PR Newswire - HighBeam Research New Analysis of CHARM Programme Provides Key Insights into Patient … - Dec 7, 2005 Candesartan cilexetil is marketed by AstraZeneca under trademark Atacand®, Ratacand®, and is manufactured under the license from Takeda Pharmaceutical ... DG News Cardiovascular Research; AT1R does not influence chronic blood … - Feb 8, 2005 ..."Candesartan cilexetil (2 mg/kg per day) was given in drinking water, ... "MAP was decreased by candesartan cilexetil, however, this effect was not further ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Cardiovascular Research; AT1R does not influence chronic blood … - Feb 12, 2005 ..."Candesartan cilexetil (2 mg/kg per day) was given in drinking water, ... "MAP was decreased by candesartan cilexetil, however, this effect was not further ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Erythema multiforme.(Disease/Disorder overview) - Dec 1, 2006 Ejaz AA, Walsh JS, Wasiluk A. Erythema multiforme associated with candesartan cilexetil. South Med J 2004;97:614-5. (22.) Sarkar R, Kaur C, Kanwar AJ. ... Free with registration - American Family Physician - AccessMyLibrary.com Heart failure patients perceive improvement in symptoms on Atacand(R)... - Jun 4, 2005 Candesartan cilexetil is marketed by AstraZeneca under trademark Atacand(R), Ratacand(R), Hytacand(R) and is manufactured under agreement from Takeda ... Medical News Today - Medical News Today (press release) Efficacia di Ratacand nei pazienti ipertesi con e senza diabete - Sep 5, 2007 Mercoledì 5 Settembre 2007 - Ricercatori del Cardiovascular Institute a Parigi ( Francia ), hanno studiato l'effetto del Candesartan Cilexetil ( Ratacand ... XagenaSalute Angiotensin; Candesartan is effective in blocking the systemic and... - Jan 31, 2005 The effects were evaluated after 4 weeks treatment with candesartan cilexetil (16 mg OD), losartan (50 mg OD) and placebo using clearance techniques." ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones AstraZeneca.(PRODUCT NEWS) | Article from Medical Marketing & Media … - Apr 1, 2005 ...find Medical Marketing & Media articles. The FDA has approved AstraZeneca's angiotensin receptor blocker Atacand (candesartan cilexetil) for the treat... Pay-Per-View - Medical Marketing & Media - HighBeam Research Angiotensin; Candesartan is effective in blocking the systemic and... - Feb 6, 2005 The effects were evaluated after 4 weeks treatment with candesartan cilexetil (16 mg OD), losartan (50 mg OD) and placebo using clearance techniques." ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Olmesartan (Benicar) for hypertension.(STEPS: New Drug Reviews) - Aug 15, 2005 The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003;34:1699-703. (8.) Dahlof B, Devereux RB, Kjeldsen SE, ... $4.95 - American Family Physician - ECNext Angiotensin; Candesartan is effective in blocking the systemic and... - Feb 4, 2005 The effects were evaluated after 4 weeks treatment with candesartan cilexetil (16 mg OD), losartan (50 mg OD) and placebo using clearance techniques." ... Pay-Per-View - Drug Week - Factiva, from Dow Jones AstraZeneca Pledges More Than $1 Million in Contributions and … - Sep 1, 2005 These medicines include: ACCOLATE(R) (zafirlukast), ARIMIDEX(R) (anastrozole), ATACAND(R) (candesartan cilexetil), ATACAND HCT(R) (candesartan ... $4.95 - PR Newswire - ECNext Article: Puzzling out difficult pediatric skin diagnoses.(Skin... - Sep 15, 2005 Treatment with candesartan cilexetil ... knowledge, this is the first report ... Words: candesartan cilexetil, erythema multiforme ********** Candesartan . ... Pay-Per-View - Family Practice News - HighBeam Research Erythema multiforme.(Disease/Disorder overview) - Dec 1, 2006 Ejaz AA, Walsh JS, Wasiluk A. Erythema multiforme associated with candesartan cilexetil. South Med J 2004;97:614-5. (22.) Sarkar R, Kaur C, Kanwar AJ. ... $4.95 - American Family Physician - ECNext Pediatric Hypertension: Does It Have an Impact on Cognition? - Jul 17, 2008 Efficacy of candesartan cilexetil in pediatric hypertensive patients 6-17 years of age: a one-year treatment trial. J Clin Hypertens. ... Medscape AstraZeneca bids $15.6B for MedImmune; posts 13% 1st-qtr 2007 EPS … - Apr 30, 2007 ...with cholesterol-lowerer Crestor revenues leaping 59% to $628.0 million and the antihypertensive Atacand (candesartan cilexetil) 11% higher at $296.0 ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Atacand HCT Medicine - Uses, Dosage & Side Effects - Apr 18, 2007 Therapy with any combination of candesartan cilexetil and hydrochlorothiazide will be associated with both sets of dose-independent side effects. ... California Chronicle Atacand cuts diabetes risk in HF patients.(Brief Article) - Jul 11, 2005 ...published in the July issue of the journal Circulation, show that AstraZeneca's angiotensin receptor blocker Atacand (candesartan cilexetil) reduces the ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Press Release: CardioDynamics Announces Two Significant Studies … - Nov 14, 2008 ...designed to specifically ... and indications from LV EF (left ventricular ejection ... Candesartan Cilexetil in Heart Failure: Assessment of Reduction . ... Pay-Per-View - PR Newswire - HighBeam Research High Blood Pressure Control is Equal with Common Medications - Nov 2, 2007 The ARBs included were candesartan cilexetil (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan medoxomil (Benicar), ... SeniorJournal.com Takeda's fiscal 2007 net profit jumps 5.9%; warns that Millennium buy... - May 19, 2008 Actos (pioglitazone), which grew 17.8% to 396.2 billion yen, and hypertension treatment Blopress (candesartan cilexetil), up 8.2% to 223.1 billion yen. ... $9.94 - Pharma Marketletter - Alacra Store AstraZeneca's Atacand reduces atrial fibrillation in hypertension.(Bri... - Jul 10, 2006 Anglo-Swedish drug major AstraZeneca says that data published in the American Heart Journal show that Atacand (candesartan cilexetil), its anti-hypertension ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Merck & Co sells JV products to AZ. - Mar 10, 2008 The US firm has elected to retain the rights to four other products within the option agreement - Atacand (candesartan cilexetil), Lexxel (enalapril and ... $9.94 - Pharma Marketletter - Alacra Store American Journal of Hypertension - Abstract of article: TAK-536, a... - Jul 18, 2006 TAK-536, on insulin resistance were explored using type 2 diabetic KK-A y mice and compared with those of candesartan cilexetil (candesartan). ... Nature.com Article: MS DRUG ON NHS.(News) - Daily Record (Glasgow, Scotland) | … - Sep 11, 2007 Beds Within the NHS The Scottish Medicines Consortium (SMC) announced today that Amias (candesartan cilexetil), an angiotensin-receptor blocker (ARB ... ... Pay-Per-View - Daily Record - HighBeam Research Press Release: SXRZF, TKPHY Have Also Been On BUYINS.NET Naked … - Aug 4, 2008 Its product line includes Leuprolide Acetate for prostate cancer and endometriosis; Lansoprazole for peptic ulcers; Candesartan Cilexetil for hypertension; ... Pay-Per-View - M2 Presswire - HighBeam Research Janssen's Invega.(PRODUCT NEWS) | Article from Medical Marketing & … - Feb 1, 2007 The FDA has accepted submission of new drug applications for AstraZeneca's Atacand HCT (candesartan cilexetil-hydrochlorothiazide) for the treatment of ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Takeda posts first-ever loss. - Aug 1, 2008 Blood pressure drug Blopress (candesartan cilexetil) posted an 8.2% increase in sales to JPY 59.9bn, while gastrointestinal drug Prevacid/Takepron ... $9.94 - M2 Europharma - Alacra Store Cardiovascular Research; Experts explore the potential benefits of … - Jun 14, 2006 It found that, compared to placebo over a four-year period, treatment of prehypertension with ATACAND (candesartan cilexetil) significantly reduced the ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Article: Serious fetal risk seen from hypertension drug - The Record... - Jun 8, 2006 THE QUESTION: Does the blood pressure drug candesartan cilexetil ... that early treatment with blood-pressure-lowering drugs called ACE inhibitors improves ... Pay-Per-View - The Record - HighBeam Research Abstract and Introduction - Nov 30, 2005 Candesartan cilexetil: an angiotensin II-receptor blocker. Am J Health-Syst Pharm. 2000; 57:739-46. Sharpe M, Jarvis B, Goa KL. Telmisartan: a review of its ... Medscape Press Release: SWDBY, TKPHY Have Also Been Removed From Naked … - Aug 12, 2008 Its product line includes Leuprolide Acetate for prostate cancer and endometriosis; Lansoprazole for peptic ulcers; Candesartan Cilexetil for hypertension; ... Pay-Per-View - M2 Presswire - HighBeam Research Takeda's income for fiscal 1st half grows 37%. - Nov 19, 2007 Actos aside, the hypertension treatment Blopress (candesartan cilexetil) providing the firm's biggest revenue contribution at 112.8 billion yen, ... $9.94 - Pharma Marketletter - Alacra Store Shire's Lialda.(PRODUCT NEWS) | Article from Medical Marketing & … - Mar 1, 2007 The FDA has accepted submission of new drug applications for AstraZeneca's Atacand HCT (candesartan cilexetil-hydrochlorothiazide) for the treatment of ... Pay-Per-View - Medical Marketing & Media - HighBeam Research AstraZeneca set to meet 2008 targets, despite 1st-qtr profit decline. - May 5, 2008 Atacand (candesartan cilexetil), an angiotensin receptor blocker, saw global revenues advance 6% to $346.0 million. In other therapy sectors, ... $9.94 - Pharma Marketletter - Alacra Store Three-Dimensional Echocardiographic and Magnetic Resonance … - Feb 3, 2005 Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil. Blood Press. 9(Suppl 1): 14–18. ... Nature.com Early Blood Pressure Treatment May Postpone True Hypertension - Mar 10, 2006 ...was funded by AstraZeneca, the pharmaceutical company that makes candesartan and sells it as ATACAND (candesartan cilexetil). ... newswise.com Wyeth's Pristiq.(PRODUCT NEWS) | Article from Medical Marketing & … - Mar 1, 2007 The FDA has accepted submission of new drug applications for AstraZeneca's Atacand HCT (candesartan cilexetil-hydrochlorothiazide) for the treatment of ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Potential Benefits Of Treating Prehypertension - May 30, 2006 It found that, compared to placebo over a four-year period, treatment of prehypertension with ATACANDй (candesartan cilexetil) significantly reduced the ... Medical News Today - Medical News Today (press release) Abstract and Introduction - Apr 8, 2005 Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Heart Disease 1999;1:52-7. Pfeffer MA, Swedberg K, ... Medscape FDA Approves Atacand for Use with an ACE Inhibitor in the Treatment... - May 22, 2005 Drug Administration (FDA) has approved a new use for its angiotensin receptor blocker (ARB) ATACAND (candesartan cilexetil) tablets for the treatment of ... Medical News Today - Medical News Today (press release) The mind and medicine.(THE PSYCHIATRIST'S TOOLBOX) - Apr 1, 2005 ...angiotensin II receptor blockers such as candesartan cilexetil (Atacand), or ACE inhibitors such as enalapril (Vasotec) in hypertensive patients. ... Free with registration - Clinical Psychiatry News - AccessMyLibrary.com Cycling without a helmet.(Letters)(Letter to the editor) - Nov 21, 2006 An advertisement for Atacand (candesartan cilexetil) that appeared in several issues of CMAJin 2006 shows an older man on a bicycle without a helmet and ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com AstraZeneca says Atacand is cost effective in treating heart failure.(... - Jun 19, 2006 AstraZeneca says that the direct cost of adding its hypertension drug Atacand (candesartan cilexetil) to standard heart failure therapy is compensated by a ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Atacand Therapy Reduces Risk of Diabetes in Heart Failure Patients - Jul 12, 2005 A reduction in the risk of developing diabetes has been shown in heart failure patients on Atacand® (candesartan cilexetil) therapy. ... Diabetes In Control New indications.(drug approvals)(Brief Article) - Mar 21, 2005 Atacand (candesartan cilexetil tablets) from AstraZeneca, Wilmington, Del., (800) 236-9933, has been granted approval for the treatment of heart failure. ... Free with registration - Drug Topics - AccessMyLibrary.com Results of the CASE-J Study, the First Large-scale Clinical Study of... - Oct 19, 2006 This is the first large-scale outcome study in Japan comparing Blopress(R), (generic name: candesartan cilexetil), angiotensin receptor blocker and ... japancorp.net Cycling without a helmet - Nov 21, 2006 An advertisement for Atacand (candesartan cilexetil) that appeared in several issues of CMAJ in 2006 shows an older man on a bicycle without a helmet and ... CMAJ Press Release: UPDATE: Nebivolol Lowers Blood Pressure in African … - Nov 1, 2007 R) (candesartan cilexetil) Lowered Blood Pressure in African Americans WAYNE, Pa., Nov. 29 /PRNewswire ... receptor blocker Atacand significantly lowers ... Pay-Per-View - PR Newswire - HighBeam Research Cardiovascular Disease; Recent studies add new data to cardiovascular... - Oct 25, 2005 ...enalapril, and a highly selective angiotensin receptor blocker, candesartan cilexetil, on indices of subcutaneous small resistance artery structure in ... Pay-Per-View - Science Letter - Factiva, from Dow Jones In Vivo and in Vitro Effects of Nebivolol on Penile Structures in … - Nov 27, 2005 Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats. Int J Impot Res. 16: 305–312. | Article | PubMed | ChemPort | ... Nature.com CHARM: new analysis shows Atacand benefit.(Candesartan in Heart … - Jun 13, 2005 ...angiotensin receptor blocker Atacand (candesartan cilexetil) perceived greater improvement in their heart failure symptoms compared to those on placebo. ... $4.95 - Pharma Marketletter - ECNext |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
